Division of Neuro-ophthalmology, Department of Ophthalmology, Massachusetts Eye and Ear.
Division of Ophthalmology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Curr Opin Ophthalmol. 2023 Jul 1;34(4):354-360. doi: 10.1097/ICU.0000000000000955. Epub 2023 Apr 18.
Optical coherence tomography angiography (OCTA) is a novel, noninvasive imaging technique, which provides depth resolved visualization of microvasculature of the retina and choroid. Although OCTA has been widely used for the evaluation of a number of retinal diseases, its use in the field of neuro-ophthalmology has been less studied. In this review, we provide an update on the utility of OCTA in neuro-ophthalmic conditions.
Peripapillary and macular microvasculature analyses have indicated that OCTA can be a promising tool for early detection of a number of neuro-ophthalmic diseases, differential diagnosis, and monitoring of disease progression. Recent studies have demonstrated that structural and functional impairment can develop at early stages in some conditions such as in multiple sclerosis and Alzheimer's disease even in the absence of overt clinical symptoms. Furthermore, this dye-less technique can be a valuable adjunct tool in the detection of complications commonly seen in some congenital entities such optic disc drusen.
Since its introduction, OCTA has emerged as an important imaging approach shedding light on unrevealed pathophysiological mechanisms of several ocular diseases. The use of OCTA as a biomarker in the field of neuro-ophthalmology has recently gained considerable attention with studies supporting its role in clinical setting while larger studies are warranted for correlating these findings with traditional diagnostic procedures and clinical features and outcomes.
光学相干断层扫描血管造影术(OCTA)是一种新颖的、非侵入性的成像技术,可提供视网膜和脉络膜微血管的深度分辨可视化。尽管 OCTA 已广泛用于许多视网膜疾病的评估,但它在神经眼科领域的应用研究较少。在这篇综述中,我们提供了 OCTA 在神经眼科疾病中的应用的最新信息。
视盘周围和黄斑区微血管分析表明,OCTA 可能是一种有前途的工具,可用于早期检测许多神经眼科疾病、鉴别诊断和监测疾病进展。最近的研究表明,即使在没有明显临床症状的情况下,一些疾病(如多发性硬化症和阿尔茨海默病)的结构和功能损伤也可能在早期阶段发生。此外,这种无染料技术在检测一些先天性疾病(如视盘玻璃疣)常见的并发症方面可以是一种有价值的辅助工具。
自引入以来,OCTA 已成为一种重要的成像方法,揭示了几种眼病的未被揭示的病理生理机制。OCTA 作为神经眼科领域的生物标志物的应用最近引起了相当大的关注,研究支持其在临床环境中的作用,而更大的研究则需要将这些发现与传统的诊断程序以及临床特征和结果相关联。